Arrhythmias and Sudden Cardiac Death
Research Focus:
Michigan Resuscitation Innovation and Science Enterprise (M-RISE)
Center Director:
Robert Neumar, MD, PhD, FAHA
Training Director:
David Pinsky, MD
Principal Investigators
- Thomas Sanderson, PhD
Early Neuroprotective Therapies for Out-of-Hospital Cardiac Arrest - Robert Silbergleit, MD, FAHA
Bystander and First Responders Clinical Trials for Early Neuroprotective Therapies in Out-of-Hospital Cardiac Arrest - Brahmajee Nallamothu, MD, MPH, FAHA
Optimizing Bystander and First Responder Time to Treatment in Out-of-Hospital Cardiac Arrest
Research Focus:
Northwestern Sudden Cardiac Death Collaboration
Center Director:
Elizabeth McNally, MD, PhD
Training Director:
Richi Arora, MD, FAHA
Principal Investigators:
- Alfred “Al” George, MD
Correlating SCD Risk with Cell Autonomous Susceptibility - Elizabeth McNally, MD, PhD
Genomics of Arrhythmias and Sudden Death - Laura Rasmussen-Torvik, PhD, MPH, FAHA
Integration of Genomics into Clinical Care for SCD
Research Focus:
Genomic and Precision Medicine Approaches to Evaluate Sex- Specific SCA Risk and Resuscitation Outcomes
Center Director:
Nona Sotoodehnia, MD, MPHD
Training Director:
Francis Kim, MD, FACC, FACP
Michael Sayre, MD, FAHA
Principal Investigators:
- Ilan Goldenberg, MD
Sex-Specific Risk for QTc Prolongation and Arrhythmic Events in Congenital and Drug Induced LQTS - Thomas Rea, MD, MPH
Precision Medicine Resuscitation: Novel Strategy for Real- Time Rhythm Assessment during CPR - Dan Arking, PhD
Genomics of Sudden Cardiac Arrest Risk among Men and Women
Research Focus:
Targeting Intracellular Calcium Leak for Ventricular Arrhythmia Prevention in Structural Heart Disease
Center Director:
Bjorn Knollmann, MD, PhD
Training Director:
Dan Roden, MD, FAHA
Principal Investigators:
- Bjorn Knollmann, MD, PhD
The Mechanistic Role of RyR2 Hyperactivity for Ventricular Arrhythmia in Animal Models - Igor Efimov, PhD
The Mechanistic Role of RyR2 Hyperactivity for Ventricular Arrhythmia in the Ex Vivo Human Heart - William Stevenson, MD
A Clinical Trial of RyR2 Inhibition to Prevent Ventricular Arrhythmias
July 2019-June 2023